Newer drugs make hepatitis C-positive kidneys safe for transplant | Science News

SCIENCE NEWS NEEDS YOU

Support nonprofit journalism

Subscribe now


News

Newer drugs make hepatitis C-positive kidneys safe for transplant

Improved antivirals could help expand the number of organs available for donation

By
3:30pm, March 8, 2018
doctors in an operating room

WELL-TREATED  Kidneys from hepatitis C-positive donors were successfully transplanted into 10 uninfected patients. The recipients did not develop chronic infections, a new study reports.

People who received kidneys from donors infected with hepatitis C did not become ill with the virus, thanks to treatment with newer drugs that can cure the disease, a small study reports.

Ten patients not previously infected with hepatitis C took doses of powerful antiviral medications before and after receiving the transplants. None of the patients developed chronic infections, researchers report online March 6 in the Annals of Internal Medicine. The finding could help make more kidneys available for transplants.

“If this increases access to transplantation, then this is a great benefit,” says Jay Fishman, a transplant infectious disease specialist at Massachusetts General Hospital in Boston.

As of January 2016, 

This article is only available to Science News subscribers. Already a subscriber? Log in now. Or subscribe today for full access.

Get Science News headlines by e-mail.

More from Science News

From the Nature Index Paid Content